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Role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to
LLC-PK1 cells. The current study was designed to test the role of
cytochrome P-450 in hydrogen peroxide-induced cytotoxicity, and to
determine whether it may serve as a source of catalytic iron. Hydrogen
peroxide led to iron release (as measured by iron/bathophenanthroline
complex) from the microsomes prepared from LLC-PK1 cells. Cimetidine,
which inhibits cytochrome P-450 by interacting with the heme iron,
significantly blocked iron release, whereas ranitidine, which has a similar
structure as cimetidine but is a weak inhibitor of P-450, did not have an
effect (H,07, 0.42 0.04; H2O + cimetidine, 0.23 0.02 nmol/mg
protein; N = 4, P < 0.01). Exposure of LLC-PK1 cells to hydrogen
peroxide (2.5 mM) resulted in a significant increase in the bleomycin-
detectable iron (iron capable of catalyzing free radical reactions) content
that was prevented by cimetidine, but not ranitidine. We then examined
the effect of the inhibitors of cytochrome P-450 on cell death (as measured
by Trypan blue exclusion) after exposure of LLC-PK1 cells to 2.5 mM
hydrogen peroxide for 120 minutes. Inhibition of eytoehrome P-450 by
cimetidine significantly reduced the cell death; the effect was observed
with 0.05 m and was concentration dependent with 1 mM affording
almost complete protection (H20,, 59 1.3% vs. H207 + cimetidine,
11 0.7%; N = 5, P < 0.01). In contrast, ranitidine did not show any
protection. We confirmed that the protective effect of cimetidine was not
related to scavenging hydrogen peroxide or hydroxyl radicals or chelating
iron. A second inhibitor of eytochrome P-450, piperonyl hutoxide, had a
similar dose-dependent beneficial effect against hydrogen peroxide-in-
duced cell injury. Our data thus indicate an important role of cytochrome
P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells and
suggest that cytochrome P-450 may serve as a source of catalytic iron.
Reactive oxygen metabolites are important mediators of isch-
ernie, toxic and immune-related tissue injury [1]. Recent studies
have implicated their role in the pathophysiology of several
models of acute renal failure [2—8]. Irreversible tubular injury is a
striking feature of acute renal failure and histological studies have
shown that the renal tubular epithelial cells are the major site of
injury in each of these models of acute renal failure [3, 9, 101.
The ability of oxidants to induce loss of cell viability in renal
tubular cells has recently been reported [10—131. Hydrogen per-
oxide is the major reactive oxygen metabolite responsible for
tissue injury [101, presumably because hydrogen peroxide is both
stable and able to freely penetrate cellular targets, where it may he
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toxic by itself or through the generation of other reactive oxygen
metabolites. Indeed, we have shown that the marked loss of cell
viability in LLC-PK1 cells, on exposure to hydrogen peroxide
(generated by glucose/glucose oxidase) is markedly reduced by
iron chelators [12].
The source of this iron that participates in hydrogen peroxide
mediated cellular injury is not known. Iron storage protein
ferritin, iron-rich mitochondria, and under certain circumstances,
extracellular heme protein such as hemoglobin and myoglobin
have all been suggested as possible sources for this iron [4, 14—171.
Several recent studies indicate that the iron rich enzyme, cyto-
chrome P-450, may serve as a source of iron in tissue injury [18,
19]. The role of cytochrome P-450 in hydrogen peroxide-induced
cytotoxicity has not been previously examined. Hence, the current
study was designed to test the role of cytochrome P-450 in
hydrogen peroxide-induced eytotoxicity to LLC-PK1 cells and to
examine the possibility that cytochrome P-450 may serve as a
source of catalytic iron.
Methods
Cell culture
LLC-PK1 cells purchased from American-Type Culture Collec
tion (CRL 1392), were maintained in Medium 199 supplemented
with 3% fetal bovine serum and penicillin (100 U/mI) in a
humidified atmosphere of 95% air—5% CO2. Confluent mono
layers were subcultured using 0.05% trypsin, 0.53 mvi EDTA in
calcium and magnesium free Hank's balanced salt solution. The
medium was changed twice a week and all experiments were
carried out on cell cultures two days post-confluency, between
passages 199 to 220.
Microsome preparation
Microsomes from LLC-PK1 cells were isolated as described by
Guzelian, Bissell and Meyer [20]. Confluent cell monolayer was
washed free of medium with 0.1 M potassium phosphate buffer
(pH 7.4) and sonieated for 10 seconds. The sonicate was then
centrifuged at 10,000 g for 20 minutes. The resulting supernatant
was centrifuged in a Beckman L-2 ultracentrifuge at 105,000 g at
4°C for 60 minutes. The microsomal pellet was resuspended in 50
mM NaCl-20% glycerol, pH 7.0 [21].
Iron mobilization from microsomal fraction
Release of iron from microsomal fraction was measured using
a method described by Ulvik and Romslo [22] and modified by
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Minotti [21] and utilized in our previous study [171. Briefly,
microsome (1 mg protein/mi), ADP (1 mM), bathophenanthroline
disulfonic acid (BPS) and test agents were incubated in 50 mi
NaC1, pH 7.0 (2 ml, final volume) at 37°C for 60 minutes. The
amount of iron released was determined using the extinction
coefficient for the Fe2 - BPS complex (E = 22.14 m cm1 at
A530 nm).
Effect of hydrogen peroxide on catalytic iron
LLC-PK1 cells were incubated with 2.5 m'vi H20, in chelex 100
resin treated HBSS. After 60 minutes 2000 U/mI of catalase was
added to stop the reaction and the incubation medium was
collected for the measurement of bleomycin-detectable iron. To
examine the effect of cytochrome P-450 on iron release, LLC-PK1
cells were preincubated with cimetidine (1 mM) or ranitidine (0.3
mM) in medium 199 devoid of serum and penicillin at 37°C for 60
minutes. The cells were then washed three times with chelexed
HBSS prior to incubating with hydrogen peroxide.
Iron capable of catalyzing free radical reactions was measured
by the bleomycin assay developed by Gutteridge and Hou [23] as
utilized in our previous study [24] and modified by Zager [25]. All
reagents except for the sample under test were made up in
chelex-treated pyrogen-free water in plastic containers and
shaken with chelex-100 to remove as much contaminating iron as
possible. The reaction mixture contained in order: 0.5 ml of calf
thymus DNA (1 mg/mI), 0.1 ml of bleomycin sulfate (0.1 U/ml),
0.1 ml of MgCI2 (50 mM), 0.1 ml of imidazole (1.0 M, pH 7.3), 0.1
ml of sample, and 0.1 ml of ascorbic acid (8 mM). Tubes were
mixed well and then incubated at 37°C for two hours with shaking.
The reaction was stopped by the addition of 0.1 ml EDTA (0.1 M)
and developed with 1.0 ml of thiobarbituric acid (1% wt/vol in 50
mM NaOH) and 1.0 ml HCI (25%, vol/vol). This reaction mixture
was then heated at 100°C for 10 minutes, cooled, and read at A532
nm. Bleomycin-detectable iron was calculated from a standard
curve (0 to 10 fLM of FeCI3 in chelex-treated pyrogen free water).
Hydrogen peroxide-induced cytotoxicily in LLC-PK1 cells
LLC-PK1 cells were harvested by trypsinization with 0.05%
trypsin-0.53 m EDTA for five minutes at 37°C. Isolated cells
were suspended in Hanks balanced salt solution (HBSS), centri-
fuged at 200 g for five minutes, and then resuspended in HBSS to
give 106 cells/mi. To determine the cytotoxicity of hydrogen
peroxide in LLC-PK1 cells, the cell suspension (106 cells/mi) was
incubated with various concentrations of hydrogen peroxide at
various time points. Cell viability was determined by use of the
Trypan blue exclusion assay [13]. In brief, 7 1J of 4% Trypan blue
was added to 90 d of the cell suspension and examined using a
hemacytometer under light microscopy. Cells failing to exclude
the dye were considered non-viable, and the data expressed as the
percentage of non-viable cells. LDH release was measured as
previously described [26].
Inhibition of cytochrome P-450
Two different inhibitors of cytochrome P-450 were used. Cime-
tidine has imidazole and cyano groups that inhibit cytochrome
P-450 by interacting with the heme iron [271. This effect of
cimetidine is specific for P-450 as it does not interact with other
heme enzymes [28]. As a control for cimetidine, ranitidine, which
has three times the H2-receptor blocking activity as cimetidine,
inhibits cytochrome P-450 either weakly or not at all [27, 29].
Piperonyl butoxide, on the other hand, yields a metabolite that
binds to heme iron of cytochrome P-450 [30, 31]. To determine
the effect of cytochrome P-450 inhibition on hydrogen peroxide-
induced cell injury in LLC-PK1 cells, the cell suspensions were
preincubated with various concentrations of cimetidine, ranitidine
or piperonyl butoxide for 30 minutes, and then incubated with 2.5
m hydrogen peroxide at 37°C for 120 minutes. Cytotoxicity was
measured by Trypan blue exclusion as described above.
Measurement of hydroxyl radical formation, hydrogen peroxide,
and iron
Hydroxyl radical formation in a cell free system was measured
by deoxyribose degradation method described by Halliwell,
Grootveid and Gutteridge [321. Briefly, 10 pA of the test agent was
mixed with 10 1d of 2-deoxy-D-ribose (300 mM), 10 pA of fer-
rous ammonium sulfate (10 mM) and 10 pA of hydrogen peroxide
(100 mM), and made up to I ml of total volume with 10 mM
phosphate buffer (pH 7.4). The solution was incubated at 37°C for
60 minutes. After incubation, the reagents were mixed with I ml
of 1% (wt/vol) solution of thiobarbituric acid in 50 mivi NaOH and
I ml of 2.8% (wt/vol) aqueous trichioroacetic acid, heated at
100°C for 15 minutes, cooled, and then read at 532 nm.
To examine whether cimetidine scavenges hydrogen peroxide, a
known amount of hydrogen peroxide (3 mM) was preincubated
with various concentrations of cimetidine (0.1 to 1 mM) for 30
minutes, and then the concentration of hydrogen peroxide was
measured by the phenol red assay [331. Briefly, 10 jLl of sample or
standard solution was added to 1 ml of buffered phenol red
solution (0.28 m phenol red, 8.5 U/mi horseradish peroxidase,
5.5 m dextrose, 10 m potassium phosphate buffer, pH 7.0, 140
mM NaCI), and incubated for five minutes at room temperature.
The reaction mixture was then brought to pH 12.5 using 10 pA of
1 N NaOH and the absorbance read at 610 nm. The amount of
hydrogen peroxide was determined using a standard curve pre-
pared with 30% hydrogen peroxide solution.
To determine whether cimetidine chelates iron, a known
amount of iron (145 xM) was preincubated with various concen-
trations of cimetidine (0.1 to 1 mM) for 30 minutes, and then the
nonheme iron assay was performed as described by Torrance and
Bothwell [34]. In brief, 0.1 ml of the sample or standard solution
was mixed with I ml of chromogen reagent (0.37 m'vi BPS and 28.6
mM thioglycolic acid) for 10 minutes at room temperature. The
absorbance was read at 532 nm against a reagent blank and the
amount of iron was determined using a standard curve prepared
with ferrous ammonium sulfate. Similarly, the effect of cimetidine
on the recovery of bleomycin-detectabie iron was examined. A
known amount of iron (FeCl3, 1 nmol/ml) was preincubated in the
absence or presence of cimetidine (0.1 to 1 mM) for 30 minutes,
and then the bleomycin assay was performed.
Cytochrome P-450 activity
Cytochrome P-450 activity was assessed by p-nitroanisole de-
methyiase as described by Bissell, Hammaker and Meyer [35]. In
brief, the LLC-PK1 cell monolayer was sonicated and centrifuged
at 18,000 g at 4°C for 10 minutes. Assay for the o-demethylase
activity was carried out on the supernatant with p-nitroanisoie as
substrate. The reaction mixture contained 10 mvi MgCI2, 5 mM
glucose-6-phosphate, 2 U/mI glucose-6-phosphate dehydrogenase,
0.4 mMp-nitroanisoie, 0.5mM NADPH and 1 mg protein/mi of the
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Fig. 1. Effect of hydrogen peroxide on iron release from microsomes in
LLC-PK1 cells. The microsomal fraction from LLC-PK1 cells (about I mg
of protein/mi) was incubated with 2.5 msi H202 for 60 minutes at 37°C. To
examine the effect of cytochrome P-450 inhibition on iron release,
microsomes were preincubated with cimetidine (CM, 1 mM) and or
ranitidine (RN, 0.3 mM) for 30 minutes, and then incubated with 2.5 mM
H202 for 60 minutes at 37°C. Iron release was measured as described in
the Methods section. Values are means SE;N = 4. P < 0.01 comparing
groups between CM + H202 and H202 alone.
Fig. 2. Effect of hydrogen peroxide on catalytic iron in LLC-PK1 cells.
LLC-PK1 cells were incubated with 2.5 mrsi H202 in chelexed HBSS. After
60 minutes 2000 U/mI of catalase was added to stop the reaction and the
incubation medium was collected for the measurement of bleomycin-
detectable iron. To examine the effect of cytochrome P-450 inhibition on
iron release, LLC-PK1 cells were preincubated with cimetidine (CM, 1
mM) or ranitidine (RN, 0.3 mM) at 37°C for 60 minutes. The cells were
then washed three times with chelexed HBSS prior to incubating with
hydrogen peroxide. Bleomycin-detectable iron release was measured as
described in the Methods section. Values are means s; N = 3. <
0.01 comparing groups between H202 versus control, and ** < 0.01
comparing groups between H202 + cimetidine versus H202 alone.
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supernatant, and made up with 100 mM potassium phosphate
buffer, pH 7.25, to a total volume of 1 ml. The absorbance change
was monitored at 405 to 490 nm and the activity of the enzyme was
calculated using an extinction coefficient of 12.87 m1 cm.
Statistical analysis
Values are expressed as mean standard error (Sc). Statistical
analyses was performed using unpaired t test (for only 2 groups)
and analysis of variance (for more than 2 groups). Statistical
significance was considered at P value < 0.05.
Materials
Tissue culture supplies were purchased from Gibco (Grand
Island, NY, USA). Cimetidine was obtained from SmithKline
Beecham Pharmaceuticals (Philadelphia, PA, USA). Ranitidine
was from Glaxo Pharmaceuticals (Research Triangle Park, NC,
USA). Piperonyl butoxide was from Aldrich Chemical Company,
Inc. (Milwaukee, WI, USA). All other chemicals werc purchased
from Sigma (St. Louis, MO, USA).
Results
To examine the possibility that cytochrome P-450 may serve as
a source of iron, we first examined the effect of hydrogen peroxide
on the iron release from the microsomes prepared from LLC-PK1
cells. Hydrogen peroxide led to an iron release as measured by
Fe2-(BPS)1 from the microsome (control, 0.12 0.01, 2.5 mvt;
H202, 0.42 0.04 nmol/mg protein; N = 4,P < 0.01). If the heme
moiety of cytochrome P-450 were the source of this iron then
cimetidine, which inhibits cytochrome P-450 by interacting with
the heme iron [28], should prevent the release of iron. We
therefore examined the effect of cytochrome P-450 inhibitor on
iron mobilization from the microsomes. As shown in Figure 1, the
increase in iron mobilization was significantly blocked by cimeti-
dine (P < 0.01), but not by ranitidine.
Most of the iron is bound to heme and non-heme proteins, and
does not directly catalyze the generation of hydroxyl radicals or a
similar oxidant [361. Gutteridge et al have described an assay
based on the use of the antibiotic, bleomycin, to detect iron
complexes capable of catalyzing free radical reactions in biological
samples [36.—39J. We examined whether iron capable of catalyzing
free radical reactions (the bleomycin-detectable iron) is increased
on exposure of LLC-PK1 cells to hydrogen peroxide. We also
examined the effect of inhibitors of cytochrome P-450. Exposure
of LLC-PK1 cells to hydrogen peroxide (2.5 mM) resulted in a
significant increase in the bleomycin-detectable iron content (Fig.
2). Cimetidine (CM, 1 mM), a P-450 inhibitor, but not ranitidine
(RN, 0.3 mM), which has a similar structure as CM but is a weak
inhibitor of P-450, prevented this marked increase in the bleomy-
cm-detectable iron content (Fig. 2).
We then examined the role of cytochrome P-450 in hydrogen
peroxide-induced cytotoxicity to LLC-PK1 cells. As shown in
Figure 3, hydrogen peroxide was cytotoxic to LLC-PK1 cells in a
time and dose dependent manner as measured by Trypan blue
exclusion. Based on these studies we then examined the effect of
the inhibitors of cytochrome P-450 after exposure of LLC-PK1
cells to 2.5 m of hydrogen peroxide for 120 minutes. Inhibition
of cytochrome P-450 by cimetidine significantly reduced the cell
injury induced by hydrogen peroxide (Fig. 4A). The effect was
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Fig. 3. A. Time course of effect of 1-1202 (5mM) on cytotoxicity (T,ypan blue
exclusion) in LLC-PK, cells. B. Concentration-dependent effect of H202
on cytotoxicity (Trypan blue exclusion; 120 mm) in LLC-PK1 cells. Values
are means Sc; N = 2 experiments performed in duplicate.
observed with 0.05 m and was concentration dependent with 1
ifiM affording almost complete protection. In contrast, ranitidine,
which has three times the H2-receptor blocking activity as cime-
tidine but is a weak inhibitor of cytochrome P-450, did not show
any protection when used in the same concentrations as cimeti-
dine (Fig. 4A). We also examined the effect of cimetidine on
hydrogen peroxide-induced cytotoxicity by using LDH release as a
marker of cell death. A marked protection against this type of
injury by cimetidine was observed [LDH release %: control 2 1;
H207 (2.5 mM) 30 2; + cimetidine (1.0 mM) 16 1; +
raniticline (0.3 mM) 25 2, N = 5, P < 0.Olj. In addition, we also
examined the effect of cimetidine on Triton-induced loss of cell
viability as previously described [401. Treatment of LLC-PK1 cells
with 0.005% Triton X-100 in serum-free DMEM for 60 minutes
resulted in significant cell death, as measured by Trypan blue
exclusion, and cimetidine failed to afford any protection against
cell death (control vs, Triton-treated, N = 3, P < 0.01), indicating
that the effect of cimetidine was not a nonspecific effect. We also
confirmed that the addition of cimetidine (1 mM) after cell death
did not interfere with the Trypan blue exclusion (data not shown).
In a separate experiment, we confirmed the inhibition of cyto-
cc
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Fig. 4. A. Effect of earious concentrations of cimetidine (CM) and ranitidine
(RN) on cytotoxicily (Typan blue exclusion) of LLC-PK, cells due to ''2°2
(2.5 mM; 120 mm). The first point (0 mM) represents the time control cells
exposed to H202 in the absence of cimetidine. *p < 0.01 compared with
cells exposed to H202 alone at concentration indicated in the figure.
Symbols are: (LI) cimetidine, (K') ranitidine. B. Effect of various concen-
trations of piperonyl butoxide on cytotoxicity (Trypan blue exclusion) of
LLC-PK1 cells due to H202 (2.5 mM; 120 mm). Values are means SE;
N = 5. The first point (0 mM) represents the time control cells exposed to
hydrogen peroxide in the absence of piperonyl butoxide. P < 0.01
compared with cells exposed to H202 alone at concentration indicated in
the figure. Symbol is (0) piperonyl butoxide.
chrome P-450 as measured by p-nitroanisole demethylase (con-
trol, 0.17 0.03; 1 mrvt cimetidine, 0.04 0.04 nmol!mg protein!
mm; N = 4, P < 0.05). A second inhibitor of cytochrome P-450,
piperonyl butoxide, had a similar dose-dependent beneficial effect
against hydrogen peroxide-induced cell injury (Fig. 4B).
We considered the possibility that the observed beneficial
effects of the. cytochrome P-450 may he due to its ability to
scavenge hydrogen peroxide. Cimetidine in concentrations be-
tween 0.1 and 1 m'vi did not scavenge hydrogen peroxide (Fig.
5A). We also confirmed that cimetidine did not chelate iron. In
these studies we found that the amount of non-heme iron (Fig.
SB) or bleomycin-detectable iron (Fig. SC) was not altered by
addition of cimetidine in concentrations between 0.1 and 1 m. In
A
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A3- Fig. 5. A. Effect of cimetidine (CM) on the recovely of 11202. A knownamount of H202 (2.5 mM) was preincubated in the absence or presence ofCM (0. ito 1 mM) for 30 minutes, and then the concentration of H202 was
measured. Values are means SE; N = 4. As shown in the figure,
cimetidine had no effect on H202 concentration. B. Effect of cimetidine
(CM) on the recovery of nonheme iron. A known amount of iron (145 jIM)
was preincubated in the absence or presence of CM (0.1 to 1 mM) for 30
minutes, and then the nonheme iron assay was performed. Values are
means SE; N = 4. As shown in the figure, the iron concentration was
unaffected by the different concentrations of cimetidine, indicating that it
did not chelate iron. C. Effect of cimetidine (CM) on the recovery of
bleomycin-detectable iron. A known amount of iron (FeCl1, 1 nmol/ml)
was preincubated in the absence or presence of CM (0.1 to 1 mM) for 30
minutes, and then the bleomycin assay was performed. Values are
means SE; N = 4.
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a cell free system, we examined whether the cytochrome P-450
inhibitors interfered with the free radical reactions. The formation
of hydroxyl radical in the presence of hydrogen peroxide and iron
(Haber-Weiss reaction) was measured by deoxyribose degrada-
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Fig. 6. Effect of various agents on hydroxyl radical formation as measured bv
deoxyribose degradation. The reaction was initiated by the addition of 1 m
H202 and 0.1 m ferrous ammonium sulfate in the presence of 3 msi
deoxyribose (LII. control). Superoxide dismutase (•, SOD, 300 U/mI),
catalase (, 50 tgIml), mannitol (tIll, 20 mM), DMSO (, 20 mM),
deferoxamine (, DFO, 10 mM), cimetidine (, 0.5 mM), ranitidine (,
0.5 mM), and piperonyl butoxide (III, 0.5 mM) was added to the reaction.
Values are means SE; N = 6. P < 0.01 compared with control.
tion. As shown in Figure 6, the reaction was inhibited by catalase,
an iron chelator (deferoxamine), and hydroxyl radical scavengers,
mannitol and DMSO. Superoxide dismutase had no effect, thus
indicating that the hydroxyl radical formation was dependent on
hydrogen peroxide and iron. Both inhibitors of cytochrome P-450,
cimetidine and piperonyl butoxide, did not scavenge hydroxyl
radical formation. Taken together, these data suggest that the
protective effect of cytochrome P-450 inhibitor on hydrogen
peroxide-induced cell injury is unlikely to be the result of scav--
enging hydroxyl radical or hydrogen peroxide or chelating iron.
Discussion
The role of cytochrome P-450 in hydrogen peroxide-mediated
cytotoxicity has not been previously examined. Our results indi-
cate that prior treatment of the cells with P-450 inhibitors resulted
in a marked preservation of cell viability against hydrogen perox.
ide-induced cytotoxicity. Ranitidine, which has three times the
H7-receptor blocking activity as cimetidine but is a weak inhibitor
of P-450, did not exhibit any protection. To increase the specificity
of our observation, two chemically distinct inhibitors of cyto-
chrome P-450 were used. We also confirmed that the protective
0 0.1 0.5 1
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effect of cimetidine was not related to scavenging hydrogen
peroxide and hydroxyl radicals or chelating iron.
The mechanism(s) by which cytochrome P-450 mediates hydro-
gen peroxide cytotoxicity in LLC-PK1 cells is not known. How-
ever, cytochrome P-450 has been suggested by Bysani et a! as a
source of iron in reperfusion injury to the rabbit lung [18], and
more recently by Paller and Jacob to the kidney [19j. Our data
provide evidence that cytochrome P-450 may serve as a significant
source of iron capable of catalyzing free radical reactions in
hydrogen peroxide-mediated injury to LLC-PK1 cells. In our
study, exposure of microsomal fraction from LLC-PK1 cells to
hydrogen peroxide led to a release of iron. This release was
prevented by cimetidine, which has imidazole and cyano groups
that interact with the heme iron of cytochrome P-450 rendering it
unavailable [271. In contrast, ranitidine, a weak inhibitor of
cytochrome P-450 [27, 291, had no effect, which suggests cyto-
chrome P-450 as the source of iron. Exposure of LLC-PK cells to
hydrogen peroxide also resulted in a significant increase in the
bleomycin-detectable (iron capable of catalyzing free radical
reactions) iron content that was prevented by cimetidine but not
ranitidine. Based on the ability of cytochrome P-450 inhibitors to
prevent iron release from microsomal fraction isolated from
LLC-PK1 cells, as well as decreasing catalytic iron content after
exposure to hydrogen peroxide, suggests that cytochrome P-450
serves as a significant source of catalytic iron in hydrogen perox-
ide-induced cytotoxicity. It appears likely that hydrogen peroxide
could lead to a direct oxidative attack on the heme moiety of
cytochrome P-450, resulting in the release of iron from the labile
heme chelate [16, 36]. In the present study we have not excluded
the possibility that iron from other sources may also play a role in
this model of cytotoxicity.
Several previous studies have examined the potential mecha-
nisms by which catalytic iron plays a role in renal tubular epithelial
cell injury. In our previous study we have shown that iron
chelators provide significant protection against hydrogen perox-
ide-induced DNA damage [111. In other prior studies we also
demonstrated an important role of intracellular calcium [41] and
an important role of calcium dependent endonuclease in oxidant-
induced damage to LLC-PK1 cells [421. The demonstration in our
subsequent study that iron chelators prevented an oxidant in-
duced increase in intracellular calcium suggests that the effect of
iron chelators in preventing oxidant-induced DNA damage may
be due, at least in part, to the prevention of oxidant-induced rise
in intracellular calcium [111. The effect of cytochrome P-450
inhibitors on this variety of processes affected by catalytic iron has
not been examined.
Our data thus indicate an important role of cytochrome P-450
in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells.
Although we have previously shown that iron plays a critical role
in hydrogen peroxide-mediated cytotoxicity to LLC-PK1 cells, the
intracellular source of this iron was not known [13]. The results of
the present study suggest that cytochrome P-450 may serve as a
source of iron in oxidant injury in various tissues.
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